SCHEMBL4904339

SCHEMBL4904339

Cc1ccc(S(=O)(=O)NCCc2nc(-c3ccccc3)sc2C)cc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.55
TP53 P04637 3/20 0.50
THRB P10828 1/20 0.49
MAPT P10636 3/20 0.48
RECQL P46063 1/20 0.43
PDE10A Q9Y233 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPK1 P28482 2/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SFRP1 Q8N474 1/20 0.42
AKR1C3 P42330 2/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901452 0.93 LMNA (0.49) LMNATP53THRBMAPTPDE10A
SCHEMBL4908254 0.92 LMNA (0.51) LMNATP53THRBMAPTALDH1A1
SCHEMBL4902495 0.91 LMNA (0.48) LMNATP53MAPTRECQLAKR1C3
SCHEMBL4904282 0.91 LMNA (0.48) LMNATP53THRBMAPTRECQL
SCHEMBL4907182 0.90 LMNA (0.46) LMNATP53THRBMAPTKMT2A
SCHEMBL4903797 0.89 LMNA (0.46) LMNATP53THRBMAPTPDE10A
SCHEMBL4905581 0.89 LMNA (0.46) LMNATP53THRBMAPTKMT2A
SCHEMBL4904262 0.88 LMNA (0.45) LMNATP53THRBMAPTPDE10A
SCHEMBL4903589 0.87 PPARA (0.49) LMNATP53MAPTPOLB
SCHEMBL4907115 0.85 MAPT (0.46) LMNATP53MAPTRECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885TP53 3421/4885THRB 160/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885TP53 3421/4885THRB 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.